The DOI matches its OpenAlex record; 42 of the 42 references it cites were found in a registry or an index.
Mechanisms for the induction of autoimmunity by infectious agents
Open accessAbstract
Autoimmune diseasesActivation and clonal expansion of autoreactive lymphocytes is a critical step in the pathogenesis of autoimmune diseases.In experimental models of autoimmunity, disease can be transferred by activated, but not resting, autoreactive T cells (1), indicating that activation of autoreactive T cells is required for the development of autoimmune diseases.Infectious agents have long been considered as possible culprits in the activation of autoreactive T cells.Mechanisms by which an infection can lead to an autoimmune process have been examined in experimental animal models, and these concepts as well as their relevance to human diseases will be discussed here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Wucherpfennig, K. W., & Strominger, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90348-8 · Cited by 1,534
Self-citationCharacterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
Lehmann, P. V., Forsthuber, T., Miller, A., & Sercarz, E. E. (1992) · Nature · doi:10.1038/358155a0 · Cited by 1,186
Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., & Hammer, R. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2359 · Cited by 1,156
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.579 · Cited by 1,009
Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J.-P., & Taurog, J. D. (1990) · Cell · doi:10.1016/0092-8674(90)90512-d · Cited by 1,005
Fujinami, R. S., & Oldstone, M. B. A. (1985) · Science · doi:10.1126/science.2414848 · Cited by 944
Cited by
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
A Proposed Classification of the Immunological Diseases
McGonagle, D., & McDermott, M. F. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030297 · Cited by 840
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521
Nohynek, H., Jokinen, J., Partinen, M., Vaarala, O., Kirjavainen, T., Sundman, J., Himanen, S.-L., Hublin, C., Julkunen, I., Olsén, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033536 · Cited by 498
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2527 · Cited by 480
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Kain, R., Exner, M., Brandes, R., Ziebermayr, R., Cunningham, D., Alderson, C. A., Davidovits, A., Raab, I., Jahn, R., Ashour, O., et al. (2008) · Nature Medicine · doi:10.1038/nm.1874 · Cited by 455
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Schultheiß, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Henkes, S.-S., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100663 · Cited by 431
Immunopathogenic mechanisms in psoriasis
GUDJONSSON, J. E., JOHNSTON, A., SIGMUNDSDOTTIR, H., & VALDIMARSSON, H. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02310.x · Cited by 397
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 389
Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., Haddad, A., Elias, M., Zisman, D., Naffaa, M. E., et al. (2021) · Vaccines · doi:10.3390/vaccines9050435 · Cited by 363
Vaccination and autoimmune disease: what is the evidence?
Wraith, D. C., Goldman, M., & Lambert, P.-H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14802-7 · Cited by 362
Autoimmune type 1 diabetes: resolved and unresolved issues
Notkins, A. L., & Lernmark, Å. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14257 · Cited by 323
Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A., & Shoenfeld, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci12337 · Cited by 303
Virus infection, antiviral immunity, and autoimmunity
Getts, D. R., Chastain, E. M. L., Terry, R. L., & Miller, S. D. (2013) · Immunological Reviews · doi:10.1111/imr.12091 · Cited by 299
Infectious causes of multiple sclerosis
Giovannoni, G., Cutter, G. R., Lunemann, J., Martin, R., Münz, C., Sriram, S., Steiner, I., Hammerschlag, M. R., & Gaydos, C. A. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70577-4 · Cited by 295
Amedei, A., Bergman, M. P., Appelmelk, B. J., Azzurri, A., Benagiano, M., Tamburini, C., van der Zee, R., Telford, J. L., Vandenbroucke-Grauls, C. M. J. E., D'Elios, M. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030530 · Cited by 288
Takahashi, T., Yujiri, T., Shinohara, K., Inoue, Y., Sato, Y., Fujii, Y., Okubo, M., Zaitsu, Y., Ariyoshi, K., Nakamura, Y., et al. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04735.x · Cited by 272
Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A., & Shoenfeld, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0212337 · Cited by 265
The risk of relapses in multiple sclerosis during systemic infections
Correale, J., Fiol, M., & Gilmore, W. (2006) · Neurology · doi:10.1212/01.wnl.0000233834.09743.3b · Cited by 256
Kaida, K., Ariga, T., & Yu, R. K. (2009) · Glycobiology · doi:10.1093/glycob/cwp027 · Cited by 155
Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., & Rose, N. R. (2004) · Autoimmunity · doi:10.1080/0891693042000196200 · Cited by 115
“– 45] Controversy exists over whether chronic inflammation triggered by infectious agents such as viruses, which can persist in tissues in genomic form for months or years, should be considered as “true” autoimmune diseases.([44]) Although most human cases of autoimmune disease are believed to be induced by persistent…”
BackgroundPodbielska, M., Levery, S. B., & Hogan, E. L. (2011) · Clinical Lipidology · doi:10.2217/clp.11.8 · Cited by 21
Metadata
- Authors
- Wucherpfennig, K. W.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2001-10-15
- Volume
- 108
- Issue
- 8
- Pages
- 1097-1104
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2135373024
- Cited by
- 435
- References
- 42
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.